Developer of a non-invasive glucometer device for diabetes patients. The company's device utilizes radiofrequency waves to continuously measure glucose levels in the blood. The device is integrated with a smartphone application to track glucose readings. The company was founded in 2017 and headquartered in Tel Aviv, Israel. It has raised $25M in series c funding. The company operates in the Life Sciences - Diabetes, HealthTech - Disease Self Management, High Tech - Wearable Technology space. Its offerings span Diabetes - Medical Devices - Monitoring Device. The company leverages advanced technology to deliver innovative solutions tailored to its target market, addressing key industry challenges and driving value for its customers.
← All startups
HAGAR
Series CDeveloper of a non-invasive glucometer device for diabetes patients. The company's device utilizes radiofrequency waves to continuously measure glucose levels in the blood. The device is integrated with a smartphone application to track glucose readings. The company was founded in 2017 and headquartered in Tel Aviv, Israel. It has raised $25M in series c funding. The company operates in the Life Sciences - Diabetes,…
About
Business model
Wearable Technology > Health and Wellness Devices > Diabetes Monitoring,
Disease Self Management > Diabetes > Monitoring > Glucose > Device > Wearable,
Diabetes > Medical Devices > Monitoring Devices > CGM > Non-Invasive
Team background
College Wise > Tel Aviv University
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Explore Life Sciences investors — funds that write checks in this sector.